Differential Cytotoxic Effects of Jaspine B in Various Cancer Cells |
Lee, Jihoon
(College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University)
Choi, Kwangik (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University) Kwon, Mihwa (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University) Lee, Dongjoo (College of Pharmacy, Ajou University) Choi, Min-Koo (College of Pharmacy, Dankook University) Song, Im-Sook (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University) |
1 | Yoo, H., Lee, Y. S., Lee, S., Kim, S. and Kim, T. Y. 2012. Pachastrissamine from pachastrissa sp. Inhibits melanoma cell growth by dual inhibition of cdk2 and erk-mediated foxo3 downregulation. Phytother. Res. 26, 1927-1933. DOI |
2 | Zhang, S., Lovejoy, K. S., Shima, J. E., Lagpacan, L. L., Shu, Y., Lapuk, A., Chen, Y., Komori, T., Gray, J. W., Chen, X., Lippard, S. J. and Giacomini, K. M. 2006. Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Res. 66, 8847-8857. DOI |
3 | Bao, L., Hazari, S., Mehra, S., Kaushal, D., Moroz, K. and Dash, S. 2012. Increased expression of p-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by mir-298. Am. J. Pathol. 180, 2490-2503. DOI |
4 | Johnson, K. R., Johnson, K. Y., Crellin, H. G., Ogretmen, B., Boylan, A. M., Harley, R. A. and Obeid, L. M. 2005. Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J. Histochem. Cytochem. 53, 1159-1166. DOI |
5 | French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K. and Smith, C. D. 2003. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 63, 5962-5969. |
6 | Gately, D. P. and Howell, S. B. 1993. Cellular accumulation of the anticancer agent cisplatin: A review. Br. J. Cancer 67, 1171-1176. DOI |
7 | Giacomini, K. M., Huang, S. M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., Ware, J. A., Wright, S. H., Yee, S. W., Zamek-Gliszczynski, M. J. and Zhang, L. 2010. Membrane transporters in drug development. Nat. Rev. Drug Discov. 9, 215-236. DOI |
8 | Indumathy, S. and Dass, C. R. 2013. Finding chemo: The search for marine-based pharmaceutical drugs active against cancer. J. Pharm. Pharmacol. 65, 1280-1301. DOI |
9 | Ishida, S., Lee, J., Thiele, D. J. and Herskowitz, I. 2002. Uptake of the anticancer drug cisplatin mediated by the copper transporter ctr1 in yeast and mammals. Proc. Natl. Acad. Sci. USA 99, 14298-14302. DOI |
10 | Katano, K., Kondo, A., Safaei, R., Holzer, A., Samimi, G., Mishima, M., Kuo, Y. M., Rochdi, M. and Howell, S. B. 2002. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res. 62, 6559-6565. |
11 | Kunkel, G. T., Maceyka, M., Milstien, S. and Spiegel, S. 2013. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat. Rev. Drug. Discov. 12, 688-702. DOI |
12 | Maceyka, M., Payne, S. G., Milstien, S. and Spiegel, S. 2002. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta. 1585, 193-201. DOI |
13 | Kuroda, I., Musman, M., Ohtani, Ii, Ichiba, T., Tanaka, J., Gravalos, D. G. and Higa, T. 2002. Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, pachastrissa sp. J. Nat. Prod. 65, 1505-1506. DOI |
14 | Kuznetsov, G., Towle, M. J., Cheng, H., Kawamura, T., Tendyke, K., Liu, D., Kishi, Y., Yu, M. J. and Littlefield, B. A. 2004. Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin b macrocyclic ketone analog e7389. Cancer Res. 64, 5760-5766. DOI |
15 | Kwon, Y., Song, J., Bae, H., Kim, W. J., Lee, J. Y., Han, G. H., Lee, S. K. and Kim, S. 2015. Synthesis and biological evaluation of carbocyclic analogues of pachastrissamine. Mar. Drugs 13, 824-837. DOI |
16 | Lim, K. G., Gray, A. I., Pyne, S. and Pyne, N. J. 2012. Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival. Br. J. Pharmacol. 166, 1605-1616. DOI |
17 | Lim, K. G., Tonelli, F., Li, Z., Lu, X., Bittman, R., Pyne, S. and Pyne, N. J. 2011. Fty720 analogues as sphingosine kinase 1 inhibitors: Enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in mcf-7 breast cancer cells. J. Biol. Chem. 286, 18633-18640. DOI |
18 | Mcgrath, T. and Center, M. S. 1988. Mechanisms of multidrug resistance in hl60 cells: Evidence that a surface membrane protein distinct from p-glycoprotein contributes to reduced cellular accumulation of drug. Cancer Res. 48, 3959-3963. |
19 | Pyne, S., Bittman, R. and Pyne, N. J. 2011. Sphingosine kinase inhibitors and cancer: Seeking the golden sword of hercules. Cancer Res. 71, 6576-6582. DOI |
20 | Mease, K., Sane, R., Podila, L. and Taub, M. E. 2012. Differential selectivity of efflux transporter inhibitors in caco-2 and mdck-mdr1 monolayers: A strategy to assess the interaction of a new chemical entity with p-gp, bcrp, and mrp2. J. Pharm. Sci. 101, 1888-1897. DOI |
21 | Russo, P., Nastrucci, C. and Cesario, A. 2011. From the sea to anticancer therapy. Curr. Med. Chem. 18, 3551-3562. DOI |
22 | Salma, Y., Lafont, E., Therville, N., Carpentier, S., Bonnafe, M. J., Levade, T., Genisson, Y. and Andrieu-Abadie, N. 2009. The natural marine anhydrophytosphingosine, jaspine b, induces apoptosis in melanoma cells by interfering with ceramide metabolism. Biochem. Pharmacol. 78, 477-485. DOI |
23 | Sato, H., Siddig, S., Uzu, M., Suzuki, S., Nomura, Y., Kashiba, T., Gushimiyagi, K., Sekine, Y., Uehara, T., Arano, Y., Yamaura, K. and Ueno, K. 2015. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells. Eur. J. Pharmacol. 746, 258-266. DOI |
24 | Shida, D., Takabe, K., Kapitonov, D., Milstien, S. and Spiegel, S. 2008. Targeting sphk1 as a new strategy against cancer. Curr. Drug. Targets 9, 662-673. DOI |
25 | Sobue, S., Iwasaki, T., Sugisaki, C., Nagata, K., Kikuchi, R., Murakami, M., Takagi, A., Kojima, T., Banno, Y., Akao, Y., Nozawa, Y., Kannagi, R., Suzuki, M., Abe, A., Naoe, T. and Murate, T. 2006. Quantitative rt-pcr analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes. Leukemia 20, 2042-2046. |
26 | Yang, J. Y., Chang, C. J., Xia, W., Wang, Y., Wong, K. K., Engelman, J. A., Du, Y., Andreeff, M., Hortobagyi, G. N. and Hung, M. C. 2010. Activation of foxo3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer. Cancer Res. 70, 4709-4718. DOI |
27 | Spiegel, S. and Milstien, S. 2003. Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat. Rev. Mol. Cell. Biol. 4, 397-407. DOI |
28 | Stoica, B. A., Movsesyan, V. A., Lea, P. M. T. and Faden, A. I. 2003. Ceramide-induced neuronal apoptosis is associated with dephosphorylation of akt, bad, fkhr, gsk-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway. Mol. Cell. Neurosci. 22, 365-382. DOI |